These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 11795035)
1. [Biotechnology for the benefit of vaccination against viral diseases: a review]. van Oirschot JT Tijdschr Diergeneeskd; 2002 Jan; 127(1):7-16. PubMed ID: 11795035 [TBL] [Abstract][Full Text] [Related]
2. Present and future of veterinary viral vaccinology: a review. van Oirschot JT Vet Q; 2001 Jul; 23(3):100-8. PubMed ID: 11513250 [TBL] [Abstract][Full Text] [Related]
3. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
4. Biotechnology and DNA vaccines for aquatic animals. Kurath G Rev Sci Tech; 2008 Apr; 27(1):175-96. PubMed ID: 18666487 [TBL] [Abstract][Full Text] [Related]
10. Overview of marker vaccine and differential diagnostic test technology. Henderson LM Biologicals; 2005 Dec; 33(4):203-9. PubMed ID: 16257545 [TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561 [TBL] [Abstract][Full Text] [Related]
12. Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine. Alvarez M; Bielsa JM; Santos L; Makoschey B Vaccine; 2007 Sep; 25(36):6613-7. PubMed ID: 17669560 [TBL] [Abstract][Full Text] [Related]
13. Virus vaccines: principles and prospects. Melnick JL Bull World Health Organ; 1989; 67(2):105-12. PubMed ID: 2663217 [TBL] [Abstract][Full Text] [Related]
14. [Fundamental safety requirements in the use of live vaccine in food animals]. Selbitz HJ Berl Munch Tierarztl Wochenschr; 2001; 114(11-12):428-32. PubMed ID: 11766270 [TBL] [Abstract][Full Text] [Related]
15. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. van Drunen Littel-van den Hurk S Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163 [TBL] [Abstract][Full Text] [Related]
16. Emergency vaccination against classical swine fever. van Oirschot JT Dev Biol (Basel); 2003; 114():259-67. PubMed ID: 14677696 [TBL] [Abstract][Full Text] [Related]
17. Application of new vaccine technologies for the control of transboundary diseases. Swayne DE Dev Biol (Basel); 2004; 119():219-28. PubMed ID: 15742632 [TBL] [Abstract][Full Text] [Related]
19. The place of marker vaccines in control and eradication of animal diseases--aspects of comparative interest. Pastoret PP Dev Biol (Basel); 2005; 121():181-8. PubMed ID: 15962481 [TBL] [Abstract][Full Text] [Related]
20. Effects of anesthesia and surgery on serologic responses to vaccination in kittens. Reese MJ; Patterson EV; Tucker SJ; Dubovi EJ; Davis RD; Crawford PC; Levy JK J Am Vet Med Assoc; 2008 Jul; 233(1):116-21. PubMed ID: 18593319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]